Stroke Cognition Calculator could help predict thinking problems after stroke
5 March 2026
Researchers at the University of Oxford have developed a “Stroke Cognition Calculator”, a new tool designed to estimate a person’s chance of having thinking and memory problems six months after a stroke.
Oxford joins new West Africa consortium to accelerate climate and health solutions
5 March 2026
Researchers from the University of Oxford have joined African universities and regional experts who are working with Wellcome to establish new science and policy consortiums that will address the escalating public health crisis driven by climate change - saving lives and livelihoods.
Digital tool that personalises antidepressant treatment significantly improves outcomes of people with depression
4 March 2026
An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.
2026 Jill and Herbert Hunt Travelling Scholarship open for applications
4 March 2026
Applications are invited for the 2026 Jill and Herbert Hunt Travelling Scholarship to support travel abroad for clinical study or research from graduates of the Oxford University Medical School.
Nuffield Department of Population Health researchers to tackle one of cancer’s toughest challenges
4 March 2026
Oxford researchers join $25m international effort to uncover immune mechanisms that protect certain people from cancer.
New study finds storytelling reduces political polarisation
3 March 2026
Study of 380 high school students finds that exchanging stories reduces affective polarisation and promotes empathy.
British children are growing taller but not for the right reasons
3 March 2026
A new analysis of Child Measurement Programme data from England, Scotland, and Wales challenges recent reports suggesting children in Britain are getting shorter. The analysis, conducted by researchers at the University of Oxford, reveals that average child height has increased over the past two decades. But these gains are not related to improved child health, the researchers say. The increases in average height are closely linked to rising childhood obesity among poorer children and widening socioeconomic inequalities.
International Advisory Board to strengthen global leadership in primary care
2 March 2026
Nuffield Department of Primary Care Health Sciences announces International Advisory Board to advance its Strategy 2025–2030 and global collaboration
Excess weight in early adulthood linked to higher risk of premature death
27 February 2026
A new study by researchers at the Nuffield Department of Population Health and in China has shown that entering adulthood with a healthy body weight is associated with a substantially lower risk of premature death from cardiovascular disease, cancer and respiratory disease. The study of approximately half a million Chinese adults is published in Science Bulletin.
Largest study of vegetarian diets and cancer shows lower risk of five cancers
27 February 2026
The largest ever study of non-meat diets and cancer risk has found that vegetarian diets are associated with lower risks of several cancers ‒ breast, prostate, kidney and pancreatic cancers, and multiple myeloma ‒ but a higher risk of squamous cell carcinoma of the oesophagus.
New study questions the evidence behind behaviour-change communication guidance for GPs
26 February 2026
Advice on how general practice staff should talk to adult patients about behaviour change is common, but new research from the Nuffield Department of Primary Care Health Sciences found that this behaviour-change communication guidance for general practice is rarely clearly substantiated with relevant evidence.
Study reveals unexpected Astrocyte enlargement enhances brain repair after transplantation
26 February 2026
Researchers have uncovered a surprising and potentially transformative finding in the field of regenerative neuroscience: xenotransplanted mouse astrocytes dramatically enlarge following implantation into the injured brain, a response that was not anticipated and that may play a critical role in improving neural repair.
AI identifies reproducible clinical subtypes of Alzheimer’s and Parkinson’s disease
26 February 2026
Published in Nature Aging today, five distinct subtypes of Alzheimer’s and Parkinson’s disease have been identified by using Artificial Intelligence to analyse healthcare data from over 100,000 patients.
New clinical trials for malaria vaccine begin in Burkina Faso
23 February 2026
Vaccinations have started at the Institut de Recherche en Sciences de la Santé – Clinical Research Unit of Nanoro (IRSS-URCN), Burkina Faso for two clinical trials to assess the blood-stage malaria vaccine candidates R78C and RH5.1 with Matrix-M (developed by the Draper Lab in the Department of Paediatrics), in combination with the R21/Matrix-M vaccine, which targets the earlier liver-stage.
Guest Lecture series: Highlighting breakthroughs in women’s health and stillbirth prevention
23 February 2026
The latest event of the Guest Lecture series welcomed Professor Sarah Stock, Programme Director of In Utero at Wellcome Leap, who delivered a compelling talk titled Breakthroughs in Women’s Health.
New bone marrow model offers scalable platform for next-generation drug discovery
23 February 2026
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long-term blood and immune cell production in a fully human 3D system.
School trips key factor in belonging at school – new survey
20 February 2026
Students value school trips most highly in fostering a sense of belonging at school, according to a survey of tens of thousands of pupils in England.
Nuffield Department of Clinical Neurosciences professors amongst first Group Leaders announced for new dedicated Parkinson's Research Centre
19 February 2026
Professors Laura Parkkinen and Peter Magill have been appointed to UK DRI Group Leader roles.
COVID-19 Vaccination During Pregnancy Offers New Insight into Preeclampsia Prevention
18 February 2026
A new multinational study from the INTERCOVID Consortium, led by researchers from the University of Oxford, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication. The findings offer unprecedented insight into preeclampsia prevention, independent of the direct effects of COVID-19 infection.
